Simple Summary CA125 has been the most promising biomarker for screening ovarian
cancer; however, it still does not have an acceptable accuracy in population-based …

Epithelial ovarian cancer (EOC) is one of the deadliest gynaecological malignancies. The
late diagnosis is frequent due to the absence of specific symptomatology and the molecular …

In most patients with ovarian carcinoma, the diagnosis is reached when the disease is long
past the initial stages, presenting already an advanced stage, and they usually have a very …

Ovarian cancer (OC) is one of the most common gynecologic cancer, which has the worst
prognosis and highest mortality rate. The lack of curative treatment and the high relapse …

Background Epithelial ovarian cancer (EOC) segmentation is an indispensable step in
assessing the extent of disease and guiding the treatment plan that follows. Currently …

Objectives To develop a radiomics signature based on multisequence magnetic resonance
imaging (MRI) to preoperatively predict peritoneal metastasis (PM) in ovarian cancer (OC) …

Primary debulking surgery (PDS) has remained the only treatment of ovarian cancer with
survival advantage since its development in the 1970s. However, survival advantage is only …

Background The tissue inhibitors of metalloproteinase (TIMPs) and their associated
metalloproteinase (MMPs) are essential regulators of tissue homeostasis and are essential …

Ovarian cancer remains a deadly diagnosis with an 85% recurrence rate and a 5-year
survival rate of only 46%. The poor outlook of this disease has improved little over the past …

Purpose Transformation of benign endometriosis to endometriosis-associated ovarian
carcinoma (EAOC) is rare; however, women with endometriosis are four times more likely to …